ArticleOxidative medicine and cellular longevity2016

NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.

Hilal S Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.